Sequenom (NAS: SQNM) is expected to report Q3 earnings on Nov. 8. Here's what Wall Street wants to see:
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Sequenom's revenues will expand 68.7% and EPS will remain in the red.
The average estimate for revenue is $22.9 million. On the bottom line, the average EPS estimate is -$0.23.
Last quarter, Sequenom recorded revenue of $18.3 million. GAAP reported sales were 37% higher than the prior-year quarter's $13.3 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, EPS came in at -$0.26. GAAP EPS were -$0.26 for Q2 versus -$0.21 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 32.2%, 3,460 basis points worse than the prior-year quarter. Operating margin was -160.2%, 300 basis points worse than the prior-year quarter. Net margin was -162.3%, 520 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $84.8 million. The average EPS estimate is -$0.92.
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 670 members out of 726 rating the stock outperform, and 56 members rating it underperform. Among 152 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 137 give Sequenom a green thumbs-up, and 15 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Sequenom is outperform, with an average price target of $6.90.
Add Sequenom to My Watchlist.
The article Can Sequenom Beat These Numbers? originally appeared on Fool.com.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.